Navigation Links
Bionic Buffer from Sigma-Aldrich

ProductsBionic Buffer from Sigma-Aldrich
Company Sigma-Aldrich
Item Bionic Buffer
Price 
Description Bionic Buffer is a unique alternative to traditional TBE (TRIS borate-EDTA) and TAE (TRIS acetate-EDTA) electrophoresis buffers. Bionic Buffer allows for higher voltage runs, extremely rapid running times, and high-resolution band separation.
-Application: Ready for use in gel electrophoresis after dilution to working 1x concentrations.
Caution: Test electrophoresis chambers to determine highest voltage. Voltages beyond the recommended range for your apparatus may result in blown fuses or damage to your apparatus. If leaving an actively running gel unattended, we recommend that you use an electrophoresis apparatus that has a timer/auto-off.
ID clarifier: 10x Concentrate
-Features& Benefits: Resolve bands in minutes • Run gels 2-3x faster than in TBE/TAE • Sharper bands in less time • Voltage less limited by heat generation
-Agarose gels may be prepared using 1x Bionic Buffer. Alternatively, Bionic Buffer is compatible with standard pre-cast or freshly made TBE and TAE gels. Researchers may choose to acclimate TBE and TAE gels to Bionic Buffer, although it has been shown not to be necessary. TBE and TAE gels run in Bionic Buffer generally produce better results than when used in their own respective buffers.
- Ready for use in gel electrophoresis after dilution to working 1x concentrations.
-Test electrophoresis chambers to determine highest voltage. Voltages beyond the recommended range for your apparatus may result in blown fuses or damage to your apparatus.If leaving an actively running gel unattended, we recommend that you use an electrophoresis apparatus that has a timer/auto-off.
-The 4L and 10L sizes are supplied in dispensers with a spigot.
- 10x Concentrate
-mode of use Voltage of 150 V is recommended for small electrophoresis chambers while a mid to large apparatus may be run at 200-250 V. User should test their chamber to determine optimum voltage.
Info Sigma-AldrichSigma-Aldrich
Sigma-Aldrich Corp.
St. Louis, MO, USA
Customer Service: 800-325-3010
Tech Support: 800-325-5832
Fax Number: 314-771-5757
Web Site: http://www.sigmaaldrich.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. 10X Capillary Electrophoresis Running Buffer from Sigma-Aldrich
2. Dulbeccos Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
3. Dulbeccos Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
4. SlideHyb Glass Array Hybridization Buffer #1 from Ambion
5. SlideHyb Glass Array Hybridization Buffer #1 from Ambion
6. AmpliTaq DNA Polymerase with Buffer I from Applied Biosystems
7. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
8. AmpliTaq DNA Polymerase, 1,000 units with Buffer I from Applied Biosystems
9. AmpliTaq DNA Polymerase with Buffer II from Applied Biosystems
10. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
11. AmpliTaq DNA Polymerase, LD with Buffer I from Applied Biosystems
Each 72-well MiniTray is low profile, with lid. Conical well shape, 10 l....
... Clone/PAD: ZMD.283. Immunogen: Fusion protein ... Specific for ASIP/PAR-3 (atypical PKC isotype-specific ... antigen is not related to the ... Human Dog Xenopus (positive controls: Caco-2 ...
For use with SSP products or any application requiring agarose gel separation • Multiple formats available to meet various throughput needs • Includes replacement parts for each un...
Request Info...
Biology Products:
(Date:4/2/2015)... , April 2, 2015 ... tests DERMALOG by far outperforms the strongest competitors, ... maintaining high accuracy, the system is capable of ... the speed proves up to be ten times ... than its runner-up performance.      (Photo: ...
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:4/1/2015)... Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces the ... wallets is underway to early access pre-order customers. ... usage at retail outlets including Walmart, Target, AT&T, Dunkin, ... Wocket was accepted at all outlets and very easy ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... in which babies are born can have a dramatic ... That is the conclusion of a new study published ... Neuroscience . The experiment provides the first evidence for ... conducted by Professor of Biological Sciences Douglas McMahon, graduate ...
... for the first time that exactly how we see our environment ... We are all familiar with the idea that our thoughts ... assume that how we perceive the visual world is usually very ... the area at the back of the brain responsible for processing ...
... reversed by activating stem cells that can repair injury in ... from the Universities of Cambridge and Edinburgh have identified a ... sheaths that protect nerve fibres in the brain. ... can be exploited to make the brain,s own stem cells ...
Cached Biology News:Babies' biological clocks dramatically affected by birth light cycle 2Babies' biological clocks dramatically affected by birth light cycle 3Babies' biological clocks dramatically affected by birth light cycle 4Babies' biological clocks dramatically affected by birth light cycle 5Seeing the world differently 2Study reveals new possibility of reversing damage caused by MS 2
(Date:4/20/2015)... Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of ... results for the fourth quarter and full year ended ... Highlights(Compared to the fourth quarter 2013) , Quarterly ... from $22.9 million in the prior year period. Excluding ... vaccine of $0.1 million in the fourth quarter of ...
(Date:4/17/2015)... 17, 2015  Centrillion Technologies, a genomic ... from the National Human Genome Research Institute, ... (NIH). The grant will help fund the ... of breakthrough genomic technologies, including phased sequencing ... Centrillion has been developing this transformative and ...
(Date:4/17/2015)... -- US-Australian drug discovery company, Novogen, today announced that ... the Feinstein Institute for Medical Research (,Feinstein Institute,) ... collaborate with the objective of developing effective treatments ... together the drug discovery expertise of Novogen and ... Institute in neurosciences and oncology. At ...
(Date:4/16/2015)... OSAKA, Japan , April 16, 2015 ... of Kyoto University and Takeda Pharmaceutical Company Limited ... to develop clinical applications of induced pluripotent stem ... mellitus, neurological disorders and cancer immunotherapy. The "Takeda-CiRA ... designed to expedite multiple research projects for drug ...
Breaking Biology Technology:Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3